Dual paraneoplastic syndrome with prostate cancer: A case of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) and humoral hypercalcemia of malignancy (HHM).
{"title":"Dual paraneoplastic syndrome with prostate cancer: A case of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) and humoral hypercalcemia of malignancy (HHM).","authors":"Junya Abe, Takashi Muranaka, Yasuharu Kunishima","doi":"10.1016/j.eucr.2025.103148","DOIUrl":null,"url":null,"abstract":"<p><p>We report the case of an 85-year-old man diagnosed with metastatic prostate cancer three years earlier. While on combined androgen blockade, he developed hematuria, hematochezia, and fatigue. These symptoms were attributed to local progression of prostate cancer and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Water restriction, palliative radiation, and tolvaptan alleviated the symptoms. Four months later, he experienced appetite loss and fatigue due to hypercalcemia, ultimately leading to a diagnosis of humoral hypercalcemia of malignancy (HHM).</p>","PeriodicalId":38188,"journal":{"name":"Urology Case Reports","volume":"62 ","pages":"103148"},"PeriodicalIF":0.4000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356318/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.eucr.2025.103148","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
We report the case of an 85-year-old man diagnosed with metastatic prostate cancer three years earlier. While on combined androgen blockade, he developed hematuria, hematochezia, and fatigue. These symptoms were attributed to local progression of prostate cancer and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Water restriction, palliative radiation, and tolvaptan alleviated the symptoms. Four months later, he experienced appetite loss and fatigue due to hypercalcemia, ultimately leading to a diagnosis of humoral hypercalcemia of malignancy (HHM).